XORTX Therapeutics Inc. (XRTX) Q1 2025 Earnings
XRTX·Reported May 19, 2025·After market close
Diluted EPS came in at $-0.19 (+84.7% YoY), beat the $-0.27 consensus by $0.08.
Diluted EPS
$-0.19beat by $0.08
Consensus: $-0.27
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2025 Earnings FAQ
Common questions about XORTX Therapeutics Inc.'s Q1 2025 earnings report.
XORTX Therapeutics Inc. (XRTX) reported Q1 2025 earnings on May 19, 2025 after market close.
XORTX Therapeutics Inc. reported diluted EPS of $-0.19 for Q1 2025.
EPS beat the consensus estimate of $-0.27 by $0.08.
Compared to the same quarter a year prior, diluted EPS grew 84.7% from $-1.24.